A hand picked selection of interesting presentations and info
Published on | 1 year ago
Programmes Enhancing EU R&IThis report presents the findings of the European Commission’s Expert Group on the COVID-19 impact on gender equality in Research and Innovation (R&I). The report highlights in particular the pandemic’s gendered impact on academic productivity, early career researchers (ECRs), and work-life balance. It investigates institutional responses and aims to bring forward unseen and marginalised experiences in academia. The recommendations are intended for R&I policymakers at national and EU-level, research funding organisations and research performing organisations. They present an opportunity for Member States and R&I organisations to apply the lessons learnt from the pandemic to the development of inclusive gender equality policies in the European Research Area (ERA). (from the report’s back cover)
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.